WAY TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS WITH  GENETIC ENGINEERED BIOLOGICAL DRUGS

dc.contributor.author	Mallaev Sh. Sh. Egamberdiev S. B. Mukhtorov M. G.
dc.date.accessioned	2024-11-21T09:02:01Z
dc.date.available	2024-11-21T09:02:01Z
dc.date.issued	2024
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/143
dc.description.abstract	The article describes the clinical and immunological features of juvenile idiopathic arthritis in children. Clinical features of the disease, laboratory analysis results are important when choosing an effective treatment method. An effective treatment method is characterized by a faster onset of remission, prolongation of its duration and reduction of side effects of drug treatment.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Web of Scientist: International Scientific Research Journal	en_US
dc.subject	juvenile idiopathic arthritis, prognosis, biological drugs	en_US
dc.title	WAY TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS WITH GENETIC ENGINEERED BIOLOGICAL DRUGS	en_US
dc.type	Article	en_US